Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres.

Katharina Carolin AlbrechtRené AschenbachIoannis DiamantisNiklas EckardtUlf K Teichgräber

Published in: Journal of cancer research and clinical oncology (2020)

Superselective DEB-TACE with 40-µm sized Embozene Tandem™ can be considered an effective and safe treatment, given the number of procedure-related complications.

Keyphrases

radiofrequency ablation
drug delivery
minimally invasive
risk factors
cancer therapy
combination therapy
molecularly imprinted
smoking cessation